Clinical Trials Study
Copyright ©The Author(s) 2024.
World J Gastroenterol. Oct 14, 2024; 30(38): 4211-4220
Published online Oct 14, 2024. doi: 10.3748/wjg.v30.i38.4211
Table 1 Clinical characteristics between two sub-groups of patients with gastric adenocarcinoma
Clinical characteristics
HER-2 positive (n = 21)
HER-2 negative (n = 80)
P value
Age (years)59.33 ± 8.53464.15 ± 10.1520.049
Sex0.221
    Male1963
    Female217
Specimen type0.007
    Gastrectomy1472
    Biopsy 78
Tumor location0.676
    Cardia1030
    Body416
    Antrum734
Differentiation degree0.001
    Poorly differentiated655
    Non-poorly differentiated1118
Lauren classification0.023
    Intestinal type822
    Diffuse type025
    Mixed type518
Table 2 Comparison of spectral-computed tomography histogram parameters and HER-2 status in gastric cancer
Parameters
HER-2 positive (n = 21)
HER-2 negative (n = 80)
P value
Min-2.000 (-5.518, 1.000)-0.500 (-7.750, 5.000)0.143
Max37.000 (29.500, 40.622)41.000 (36.000, 50.750)0.018
Mean17.429 (14.923, 19.341)21.176 (17.529, 25.899)0.001
Std4.383 (3.663, 4.949)5.037 (4.285, 5.883)0.015
Variance19.198 (13.417, 24.489)25.366 (18.359, 34.604)0.015
CV0.269 ± 0.0670.245 ± 0.0710.163
Skewness-0.051 (-0.246, 0.020)-0.064 (-0.289, 0.182) 0.569
Kurtosis0.282 (0.020, 0.683) 0.280 (0.037, 0.617) 0.861
Entropy2.843 ± 0.2563.012 ± 0.2590.009
1st percentile6.037 (3.500, 9.000) 9.000 (6.000, 12.75) 0.007
5th percentile10.000 (7.000, 12.000) 12.500 (10.000, 16.750) 0.003
10th percentile11.000 (9.000, 13.500) 14.000 (12.000, 18.750) 0.003
25th percentile14.086 (12.000, 16.500)17.000 (14.000, 21.750) 0.002
50th percentile18.000 (15.000, 19.500) 21.000 (18.000, 25.750) 0.001
75th percentile20.122 (18.000, 23.000) 24.000 (21.000, 30.500) 0.001
90th percentile24.000 (19.500, 26.000) 27.000 (24.000, 35.000) 0.001
95th percentile24.147 (21.000, 28.000) 29.000 (25.000, 37.750) 0.001
99th percentile28.171 (24.000, 30.500) 32.500 (28.000, 40.750) 0.001
Lesion volume14.643 (4.214, 41.820) 9.930 (4.418, 21.191) 0.266
Table 3 Receiver operating characteristic curve results of the iodine map histogram parameters to identify HER-2 status
Parameters
AUC (95%CI)
Sensitivity (%)
Specificity (%)
Accuracy (%)
Cutoff value
P value
Youden index
Max0.66976.253.758.440.620.0180.299
Mean0.73481.061.265.319.540.0010.422
SD0.67485.750.057.45.050.0150.357
Variance0.67485.750.057.425.500.0150.357
Entropy0.69885.750.757.43.020.0050.357
1st percentile0.69185.747.555.49.180.0070.332
5th percentile0.70871.460.062.411.500.0030.314
10th percentile0.71376.257.561.413.500.0030.337
25th percentile0.71576.258.762.415.500.0030.349
50th percentile0.73676.261.264.419.500.0010.374
75th percentile0.73181.055.060.427.500.0010.360
90th percentile0.73366.771.270.324.570.0010.379
95th percentile0.73771.467.568.326.500.0010.389
99th percentile0.74076.265.067.330.500.0010.412
Table 4 Correlations between spectral-computed tomography histogram parameters and HER-2 status of gastric cancers
Parameters
Correlation coefficient
P value
Max-0.2370.017
Mean-0.3290.001
SD-0.2440.014
Variance-0.2440.014
Entropy-0.2780.005
1st percentile-0.2700.006
5th percentile-0.2930.003
10th percentile-0.3000.002
25th percentile-0.3030.002
50th percentile-0.3320.001
75th percentile-0.3250.001
90th percentile-0.3280.001
95th percentile-0.3330.001
99th percentile-0.3370.001